首页> 外文期刊>World Journal of Surgical Oncology >Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials
【24h】

Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials

机译:人工淋巴引流对乳腺癌相关淋巴水肿的影响:随机对照试验的系统评价和荟萃分析

获取原文
           

摘要

Background Lymphedema is a common complication of axillary dissection for breast cancer. We investigated whether manual lymphatic drainage (MLD) could prevent or manage limb edema in women after breast-cancer surgery. Methods We performed a systematic review and meta-analysis of published randomized controlled trials (RCTs) to evaluate the effectiveness of MLD in the prevention and treatment of breast-cancer-related lymphedema. The PubMed, EMBASE, CINAHL, Physiotherapy Evidence Database (PEDro), SCOPUS, and Cochrane Central Register of Controlled Trials electronic databases were searched for articles on MLD published before December 2012, with no language restrictions. The primary outcome for prevention was the incidence of postoperative lymphedema. The outcome for management of lymphedema was a reduction in edema volume. Results In total, 10 RCTs with 566 patients were identified. Two studies evaluating the preventive outcome of MLD found no significant difference in the incidence of lymphedema between the MLD and standard treatment groups, with a risk ratio of 0.63 and a 95% confidence interval (CI) of 0.14 to 2.82. Seven studies assessed the reduction in arm volume, and found no significant difference between the MLD and standard treatment groups, with a weighted mean difference of 75.12 (95% CI, ?9.34 to 159.58). Conclusions The current evidence from RCTs does not support the use of MLD in preventing or treating lymphedema. However, clinical and statistical inconsistencies between the various studies confounded our evaluation of the effect of MLD on breast-cancer-related lymphedema.
机译:背景淋巴水肿是乳腺癌腋窝夹层的常见并发症。我们调查了在乳腺癌手术后,手动淋巴引流(MLD)是否可以预防或控制女性的肢体水肿。方法我们对已发表的随机对照试验(RCT)进行了系统的回顾和荟萃分析,以评估MLD在预防和治疗乳腺癌相关淋巴水肿中的有效性。搜索PubMed,EMBASE,CINAHL,物理疗法证据数据库(PEDro),SCOPUS和Cochrane对照试验中央登记册电子数据库,以查找2012年12月之前发布的关于MLD的文章,没有语言限制。预防的主要结果是术后淋巴水肿的发生率。处理淋巴水肿的结果是水肿量减少。结果共鉴定出10例RCT,共566例患者。两项评估MLD预防结果的研究发现,MLD与标准治疗组之间淋巴水肿的发生率无显着差异,风险比为0.63,95%置信区间(CI)为0.14至2.82。七项研究评估了手臂体积的减少,发现MLD与标准治疗组之间无显着差异,加权平均差异为75.12(95%CI,?9.34至159.58)。结论RCT的当前证据不支持MLD预防或治疗淋巴水肿。但是,各种研究之间的临床和统计不一致使我们对MLD对乳腺癌相关淋巴水肿的作用的评估感到困惑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号